Earnings Season - Raffles Medical Group
Raffles Medical Group had a revenue of $382.3 million in the first half of financial year 2022. The Group’s net profit was $59.7 million and earnings per share increased from 3.19 to 2.11 cents per share. The group also received approval to open an In-Vitro Fertilisation/Assisted Reproductive Therapy Centre at Le Cheng Hainan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments